Natural course of post COVID-19 condition and implications for trial design and outcome selection: A population-based longitudinal cohort study
View ORCID ProfileTala Ballouz, View ORCID ProfileDominik Menges, View ORCID ProfileAlexia Anagnostopoulos, View ORCID ProfileAnja Domenghino, View ORCID ProfileHélène E Aschmann, View ORCID ProfileAnja Frei, View ORCID ProfileJan S Fehr, View ORCID ProfileMilo A Puhan
doi: https://doi.org/10.1101/2022.06.22.22276746
Tala Ballouz
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Dominik Menges
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Alexia Anagnostopoulos
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Anja Domenghino
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
2Department of Visceral and Transplantation Surgery, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland
Hélène E Aschmann
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
3Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA
Anja Frei
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Jan S Fehr
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Milo A Puhan
1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted June 22, 2022.
Natural course of post COVID-19 condition and implications for trial design and outcome selection: A population-based longitudinal cohort study
Tala Ballouz, Dominik Menges, Alexia Anagnostopoulos, Anja Domenghino, Hélène E Aschmann, Anja Frei, Jan S Fehr, Milo A Puhan
medRxiv 2022.06.22.22276746; doi: https://doi.org/10.1101/2022.06.22.22276746
Natural course of post COVID-19 condition and implications for trial design and outcome selection: A population-based longitudinal cohort study
Tala Ballouz, Dominik Menges, Alexia Anagnostopoulos, Anja Domenghino, Hélène E Aschmann, Anja Frei, Jan S Fehr, Milo A Puhan
medRxiv 2022.06.22.22276746; doi: https://doi.org/10.1101/2022.06.22.22276746
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2835)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12539)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4416)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2843)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4170)
- Nursing (220)
- Nutrition (615)
- Oncology (2196)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6759)
- Radiology and Imaging (1486)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)